Page 1 | Search Results | Cancer Epidemiology, Biomarkers & Prevention

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Abstract B125: Use of ambulatory surgery centers for breast cancer surgery is associated with better survival: A population-based assessment in California

Lihua Liu, Juanjuan Zhang, Kathy Wojcik, Irene Kang, Mary Falcone, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2023) 32 (1_Supplement): B125.

https://doi.org/10.1158/1538-7755.DISP22-B125

Published: 01 January 2023

View article titled, Abstract B125: Use of ambulatory surgery centers for breast cancer surgery is associated with better survival: A population-based assessment in California

Journal Articles

Assessing the Coverage of US Cancer Center Primary Catchment Areas

Amy E. Leader, Christopher McNair, Christina Yurick, Matthew Huesser, Elizabeth Schade, Emily E. Stimmel, Caryn Lerman, Karen E. Knudsen

Cancer Epidemiol Biomarkers Prev (2022) 31 (5): 955–964.

https://doi.org/10.1158/1055-9965.EPI-21-1097

Published: 04 May 2022

View article titled, Assessing the Coverage of US Cancer Center Primary Catchment Areas

Includes: Supplementary data

Journal Articles

Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer

Mary Falcone, Chongliang Luo, Yong Chen, David Birtwell, Martin Cheatle, Rui Duan, Peter E. Gabriel, Lifang He, Emily M. Ko, Heinz-Josef Lenz, Nebojsa Mirkovic, Danielle L. Mowery, E. Andrew Ochroch, E. Carter Paulson, Emily Schriver, Robert A. Schnoll, Justin E. Bekelman, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2020) 29 (11): 2126–2133.

https://doi.org/10.1158/1055-9965.EPI-20-0628

Published: 02 November 2020

View article titled, Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer

Includes: Supplementary data

Journal Articles

A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine

Taraneh Taghavi, Maria Novalen, Caryn Lerman, Tony P. George, Rachel F. Tyndale

Cancer Epidemiol Biomarkers Prev (2018) 27 (8): 882–891.

https://doi.org/10.1158/1055-9965.EPI-18-0018

Published: 31 July 2018

View article titled, A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine

Includes: Supplementary data

Journal Articles

Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation

Julie-Anne Tanner, Maria Novalen, Peter Jatlow, Marilyn A. Huestis, Sharon E. Murphy, Jaakko Kaprio, Aino Kankaanpää, Laurence Galanti, Cristiana Stefan, Tony P. George, Neal L. Benowitz, Caryn Lerman, Rachel F. Tyndale

Cancer Epidemiol Biomarkers Prev (2015) 24 (8): 1239–1246.

https://doi.org/10.1158/1055-9965.EPI-14-1381

Published: 02 August 2015

View article titled, Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation

Includes: Supplementary data

Journal Articles

Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers

Meghan J. Chenoweth, Maria Novalen, Larry W. Hawk, Jr, Robert A. Schnoll, Tony P. George, Paul M. Cinciripini, Caryn Lerman, Rachel F. Tyndale

Cancer Epidemiol Biomarkers Prev (2014) 23 (9): 1773–1782.

https://doi.org/10.1158/1055-9965.EPI-14-0427

Published: 01 September 2014

View article titled, Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers

Journal Articles

Validation of a paradigm for screening medications for nicotine dependence.

Freda Patterson, Christopher Jepson, Joseph Frey, Kenneth Perkins, Andrew Strasser, Anna Boonin, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2007) 16 (12_Supplement): A33.

Published: 15 August 2014

View article titled, Validation of a paradigm for screening medications for nicotine dependence.

Journal Articles

The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex

Andy Z.X. Zhu, Caroline C. Renner, Dorothy K. Hatsukami, Gary E. Swan, Caryn Lerman, Neal L. Benowitz, Rachel F. Tyndale

Cancer Epidemiol Biomarkers Prev (2013) 22 (4): 708–718.

https://doi.org/10.1158/1055-9965.EPI-12-1234-T

Published: 02 April 2013

View article titled, The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex

Includes: Supplementary data

Journal Articles

Nicotinic Acetylcholine Receptor β2 Subunit (CHRNB2) Gene and Short-Term Ability to Quit Smoking in Response to Nicotine Patch

Kenneth A. Perkins, Caryn Lerman, Melissa Mercincavage, Carolyn A. Fonte, Jessica L. Briski

Cancer Epidemiol Biomarkers Prev (2009) 18 (10): 2608–2612.

https://doi.org/10.1158/1055-9965.EPI-09-0166

Published: 08 October 2009

View article titled, Nicotinic Acetylcholine Receptor β2 Subunit (CHRNB2) Gene and Short-Term Ability to Quit Smoking in Response to Nicotine Patch

Journal Articles

Cancer Epidemiology, Biomarkers & Prevention, and Cancer Prevention Research: Two Journals, a Common Goal

Timothy R. Rebbeck, Powel H. Brown, Ernest T. Hawk, Caryn Lerman, Electra D. Paskett, Thomas A. Sellers, Scott M. Lippman, for the CEBP Senior Editors and CaPR Deputy and Senior Editors

Cancer Epidemiol Biomarkers Prev (2008) 17 (11): 2903–2905.

https://doi.org/10.1158/1055-9965.EPI-08-0888

Published: 06 November 2008

View article titled, Cancer Epidemiology, Biomarkers & Prevention, and Cancer Prevention Research: Two Journals, a Common Goal

Journal Articles

CYP2B6 Genotype Does Not Alter Nicotine Metabolism, Plasma Levels, or Abstinence with Nicotine Replacement Therapy

Anna M. Lee, Christopher Jepson, Peter G. Shields, Neal Benowitz, Caryn Lerman, Rachel F. Tyndale

Cancer Epidemiol Biomarkers Prev (2007) 16 (6): 1312–1314.

https://doi.org/10.1158/1055-9965.EPI-07-0188

Published: 04 June 2007

View article titled, CYP2B6 Genotype Does Not Alter Nicotine Metabolism, Plasma Levels, or Abstinence with Nicotine Replacement Therapy

Journal Articles

Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial

Marcus R. Munafò, Elaine C. Johnstone, E. Paul Wileyto, Peter G. Shields, Katherine M. Elliot, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2006) 15 (2): 398–400.

https://doi.org/10.1158/1055-9965.EPI-05-0648

Published: 21 February 2006

View article titled, Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial

Journal Articles

A Randomized Controlled Trial of Financial Incentives for Smoking Cessation

Kevin G. Volpp, Andrea Gurmankin Levy, David A. Asch, Jesse A. Berlin, John J. Murphy, Angela Gomez, Harold Sox, Jingsan Zhu, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2006) 15 (1): 12–18.

https://doi.org/10.1158/1055-9965.EPI-05-0314

Published: 24 January 2006

View article titled, A Randomized Controlled Trial of Financial Incentives for Smoking Cessation

Journal Articles

Catechol-O-Methyl-Transferase Functional Polymorphism and Nicotine Dependence: an Evaluation of Nonreplicated Results

David T. Redden, Peter G. Shields, Leonard Epstein, E. Paul Wileyto, Stanislav O. Zakharkin, David B. Allison, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2005) 14 (6): 1384–1389.

https://doi.org/10.1158/1055-9965.EPI-04-0649

Published: 07 June 2005

View article titled, Catechol-O-Methyl-Transferase Functional Polymorphism and Nicotine Dependence: an Evaluation of Nonreplicated Results

Journal Articles

Behavioral Consequences of Testing for Obesity Risk

Dominick L. Frosch, Paul Mello, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2005) 14 (6): 1485–1489.

https://doi.org/10.1158/1055-9965.EPI-04-0913

Published: 07 June 2005

View article titled, Behavioral Consequences of Testing for Obesity Risk

Journal Articles

Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients

Marc D. Schwartz, Caryn Lerman, Barbara Brogan, Beth N. Peshkin, Claudine Isaacs, Tiffani DeMarco, Chanita Hughes Halbert, Marie Pennanen, Clinton Finch

Cancer Epidemiol Biomarkers Prev (2005) 14 (4): 1003–1007.

https://doi.org/10.1158/1055-9965.EPI-03-0545

Published: 11 April 2005

View article titled, Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients

Journal Articles

Smoking Topography Predicts Abstinence following Treatment with Nicotine Replacement Therapy

Andrew A. Strasser, Wallace B. Pickworth, Freda Patterson, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2004) 13 (11): 1800–1804.

https://doi.org/10.1158/1055-9965.1800.13.11

Published: 08 November 2004

View article titled, Smoking Topography Predicts Abstinence following Treatment with Nicotine Replacement Therapy

Journal Articles

Predictors of Participation in Psychosocial Telephone Counseling following Genetic Testing for BRCA1 and BRCA2 Mutations

Chanita Hughes Halbert, Lari Wenzel, Caryn Lerman, Beth N. Peshkin, Steven Narod, Alfred Marcus, Camille Corio, Tiffani Demarco, Scarlett Bellamy

Cancer Epidemiol Biomarkers Prev (2004) 13 (5): 875–881.

https://doi.org/10.1158/1055-9965.875.13.5

Published: 24 May 2004

View article titled, Predictors of Participation in Psychosocial Telephone Counseling following Genetic Testing for BRCA1 and BRCA2 Mutations

Journal Articles

Individual Differences in Nicotine Intake per Cigarette

Freda Patterson, Neal Benowitz, Peter Shields, Vyga Kaufmann, Christopher Jepson, Paul Wileyto, Susan Kucharski, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2003) 12 (5): 468–471.

Published: 01 May 2003

View article titled, Individual Differences in Nicotine Intake per Cigarette

Journal Articles

Utilization of Breast Cancer Screening in a Clinically Based Sample of Women after BRCA1/2 Testing

Beth N. Peshkin, Marc D. Schwartz, Claudine Isaacs, Chanita Hughes, David Main, Caryn Lerman

Cancer Epidemiol Biomarkers Prev (2002) 11 (10): 1115–1118.

Published: 01 October 2002

View article titled, Utilization of Breast Cancer Screening in a Clinically Based Sample of Women after BRCA1/2 Testing

NARROW

Abstract B125: Use of ambulatory surgery centers for breast cancer surgery is associated with better survival: A population-based assessment in California

Assessing the Coverage of US Cancer Center Primary Catchment Areas

Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer

A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine

Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation

Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers

Validation of a paradigm for screening medications for nicotine dependence.

The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex

Nicotinic Acetylcholine Receptor β2 Subunit (CHRNB2) Gene and Short-Term Ability to Quit Smoking in Response to Nicotine Patch

Cancer Epidemiology, Biomarkers & Prevention, and Cancer Prevention Research: Two Journals, a Common Goal

CYP2B6 Genotype Does Not Alter Nicotine Metabolism, Plasma Levels, or Abstinence with Nicotine Replacement Therapy

Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial

A Randomized Controlled Trial of Financial Incentives for Smoking Cessation

Catechol-O-Methyl-Transferase Functional Polymorphism and Nicotine Dependence: an Evaluation of Nonreplicated Results

Behavioral Consequences of Testing for Obesity Risk

Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients

Smoking Topography Predicts Abstinence following Treatment with Nicotine Replacement Therapy

Predictors of Participation in Psychosocial Telephone Counseling following Genetic Testing for BRCA1 and BRCA2 Mutations

Individual Differences in Nicotine Intake per Cigarette

Utilization of Breast Cancer Screening in a Clinically Based Sample of Women after BRCA1/2 Testing

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only